| Home | E-Submission | Sitemap | Contact Us |  
Journal of Breast Disease > Volume 12(1); 2024 > Article
Journal of Breast Disease 2024;12(1): 1-11. doi: https://doi.org/10.14449/jbd.2024.12.1.1
Systemic Treatment After Locoregional Recurrence in Breast Cancer: A Review
Min Kyoon Kim, M.D., Ph.D.
Department of Surgery, Chung-Ang University College of Medicine, Seoul, Korea
Corresponding Author: Min Kyoon Kim ,Tel: +82-2-6299-1562, Fax: +82-2-6299-1545, Email: minkyoon96@cau.ac.kr
Received: June 7, 2024    Accepted: June 19, 2024
Share :  
Locoregional recurrence (LRR) in breast cancer poses significant challenges due to its association with biologically resistant disease and a high likelihood of concurrent occult systemic disease. Despite advancements in local and systemic therapies, LRR affects a substantial percentage of patients, leading to poorer prognosis compared to those with primary breast cancer. Therefore, a comprehensive review of systemic treatment strategies following LRR is warranted to address the gaps in our understanding and improve patient outcomes. This review explored factors influencing the prognosis of breast cancer LRR. In particular, we evaluated the benefits of systemic treatment options post-resection and proposed an optimal treatment algorithm.
Keywords: Breast neoplasms | Chemotherapy | Drug resistant | Recurrence | Treatment switching
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Editorial Office
519-763, 전라남도 화순군 화순읍 서양로 322
TEL : 061-379-7646    FAX : 061-379-7661    E-mail : jbd@kbcs.or.kr

Copyright© Korean Breast Cancer Society.                Developed in M2PI
About |  Browse Articles |  Current Issue |  For Authors and Reviewers